Commercial Medical Devices

MHRA and NICE Open Evidence Call on Digital Mental Health Technologies Resources

Samira HaleNovember 8, 20265 min read2 views

At a glance

  • The survey runs until 26 February 2027 and will help set the direction of the second phase of the Wellcome-funded DMHT programme.
  • MHRA and NICE have launched a call for evidence on resources produced under the Wellcome-funded Digital Mental Health Technologies programme, with responses open until 26 February 2027 to inform Phase 2.
A stylised tablet showing abstract wellbeing graphics stands among translucent document sheets and a magnifying glass in a teal-and-amber concept illustration.

The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have opened a call for evidence on resources developed under the Wellcome-funded Digital Mental Health Technologies (DMHT) programme. The survey opened on 5 November 2026 and will remain open until 26 February 2027.

The exercise forms part of the programme's Phase 1 evaluation. According to the two organisations, it is intended to establish how the resources have been received and used across the sector, and whether the materials have influenced users' knowledge, confidence, decision-making and professional practice.

Who is being asked to respond

The agencies are seeking feedback from a broad set of stakeholders:

  • developers and manufacturers of digital mental health technologies;
  • healthcare professionals;
  • researchers, policymakers and regulators;
  • people with lived experience of mental health conditions, carers and members of the public.

Respondents are encouraged to take part whether they have engaged with the existing materials extensively, minimally or not at all. The agencies say the feedback will be used to identify strengths, highlight areas for improvement and shape future work on the safety and effectiveness of digital mental health technologies.

Purpose of the resources

The materials were produced to support the safe development, regulation, evaluation and adoption of digital mental health technologies, a category that includes mental health apps and other digital tools. Findings from the survey will be used to judge whether the Phase 1 outputs met their intended objectives and to inform the future direction of Phase 2 of the DMHT programme.

Reported by Samira Hale, Infection Control, Quality and Procurement Editor.